GRAIL Advances Galleri FDA Review for Cancer Detection
Menlo Park, California, USA, August 8, 2026 GRAIL, Inc. has announced a major regulatory milestone as the U.S. Food...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Menlo Park, California, USA, August 8, 2026 GRAIL, Inc. has announced a major regulatory milestone as the U.S. Food...
Woburn, Massachusetts, USA, August 8, 2026 Replimune Group, Inc. has achieved a significant regulatory milestone with the U.S. Food...
Shanghai, China, May 23, 2026 Henlius Biotech has announced that the Committee for Medicinal Products for Human Use (CHMP)...
